NeuroOne Medical Technologies (NASDAQ:NMTC) specializes in developing and commercializing innovative neurological diagnosis and therapy solutions. These cutting-edge technologies are designed to assist healthcare professionals in improving the outcomes for patients suffering from neurological disorders and providing a higher standard of care. NeuroOne's focus encompasses a wide range of neurological applications, highlighting their commitment to advancing the field through continuous innovation. The objective of the company is to make significant strides in neurological care by bringing state-of-the-art devices and systems that offer improved patient outcomes and operational efficiencies in healthcare settings.